SCHEMBL9576485

SCHEMBL9576485

CC(CC=CC=CC(=O)O)CCCCC1OC(=O)C1CO

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DAGLA Q9Y4D2 8/20 0.35
▸ CNR1 P21554 5/20 0.35
▸ DAGLB Q8NCG7 3/20 0.34
▸ MGLL Q99685 1/20 0.34
▸ PRKCA P17252 2/20 0.33
▸ PRKD3 O94806 1/20 0.33
▸ PRKCG P05129 1/20 0.33
▸ PRKCB P05771 1/20 0.33
▸ PRKCH P24723 1/20 0.33
▸ PRKCE Q02156 1/20 0.33
▸ PRKCQ Q04759 1/20 0.33
▸ PRKCD Q05655 1/20 0.33
▸ PRKD1 Q15139 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ NR1I2 O75469 1/20 0.33
▸ ABHD16A O95870 1/20 0.33
▸ LPL P06858 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ LIPC P11150 1/20 0.33
▸ PNLIP P16233 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9576484 1.00 DAGLA (0.35) DAGLACNR1DAGLBMGLLPRKCA
SCHEMBL9718248 0.88 DAGLA (0.36) DAGLACNR1DAGLBMGLLPRKCA
SCHEMBL9718250 0.88 DAGLA (0.36) DAGLACNR1DAGLBMGLLPRKCA
SCHEMBL10367940 0.75 PRKCA (0.41) DAGLACNR1DAGLBMGLLPRKCA
SCHEMBL9580585 0.74 — —
Antibiotic 1233A SCHEMBL613745 0.74 PRKCA (0.35) DAGLACNR1DAGLBMGLLPRKCA
Antibiotic 1233A SCHEMBL285680 0.74 PRKCA (0.35) DAGLACNR1DAGLBMGLLPRKCA
Antibiotic 1233A SCHEMBL285679 0.74 PRKCA (0.35) DAGLACNR1DAGLBMGLLPRKCA
SCHEMBL9825431 0.73 DAGLA (0.38) DAGLACNR1DAGLBPRKCAPRKD3
SCHEMBL5495024 0.72 PRKCA (0.38) DAGLACNR1DAGLBMGLLPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5214067-A Mixture of pyranyl glycine ester and beta-lactone MERCK & CO., INC. (US) 1993-05-25 — — US claimed
EP-0479356-A1 Fungicidal compositions and method MERCK & CO. INC. (US) 1992-04-08 — — EP claimed
US-4988697-A Alpha-demethylase inhibiting azole compound and a beta-lactone MERCK & CO., INC. (US) 1991-01-29 — — US claimed
US-4920113-A TO ERADICATE MYCOTIC INFECTIONS; NONTOXIC, SIDE EFFECT REDUCTION MERCK & CO., INC. (US) 1990-04-24 — — US claimed
EP-0339708-A2 Fungicidal compositions and method MERCK & CO. INC. (US) 1989-11-02 — — EP claimed
JP-1311025-A — — None — — JP disclosed
US-5214067-A Mixture of pyranyl glycine ester and beta-lactone MERCK & CO., INC. (US) 1993-05-25 — — US disclosed
EP-0339709-B1 ANTIFUNGAL COMPOSITIONS AND METHOD OF CONTROLLING MYCOTIC INFECTIONS MERCK & CO. INC. (US) 1993-03-31 — — EP disclosed
EP-0479356-A1 Fungicidal compositions and method MERCK & CO. INC. (US) 1992-04-08 — — EP disclosed
US-4988697-A Alpha-demethylase inhibiting azole compound and a beta-lactone MERCK & CO., INC. (US) 1991-01-29 — — US disclosed
US-4921844-A 25-AZASTEROLS, B-KETOTHIOLASE INHIBITORS MERCK & CO., INC. (US) 1990-05-01 — — US disclosed
US-4920111-A SYNERGISTIC MERCK & CO., INC. (US) 1990-04-24 — — US disclosed
US-4920109-A COADMINISTERING A 25-AZASTEROL WITH A NON-STEROIDAL AGENT; NONTOXIC, SIDE EFFECT REDUCTION MERCK & CO., INC. (US) 1990-04-24 — — US disclosed
US-4920113-A TO ERADICATE MYCOTIC INFECTIONS; NONTOXIC, SIDE EFFECT REDUCTION MERCK & CO., INC. (US) 1990-04-24 — — US disclosed
US-4920112-A SYNERGISTIC 25-AZASTEROL COMPOUND AND SQUALENE EPOXIDASE INHIBITOR MERCK & CO., INC. (US) 1990-04-24 — — US disclosed
JP-H01311025-A FUNGICIDAL COMPOSITION AND METHOD MERCK & CO INC 1989-12-15 — — JP disclosed
EP-0339709-A2 Antifungal compositions and method of controlling mycotic infections MERCK & CO. INC. (US) 1989-11-02 — — EP disclosed
EP-0339708-A2 Fungicidal compositions and method MERCK & CO. INC. (US) 1989-11-02 — — EP disclosed
Send feedback